Get your Politiken Edition subscription

170,000 have already purchased Novo Nordisk’s weight loss pill since its launch in the U.S. in January. But suddenly, similar pills could be bought at half the price from a completely different company.

Expert after turbulent week: »It's a huge plus for Novo Nordisk«

In January 2026, Novo Nordisk began offering the weight loss medication Wegovy in pill form in the U.S. Foto: Reuters/Ritzau Scanpix
In January 2026, Novo Nordisk began offering the weight loss medication Wegovy in pill form in the U.S. Foto: Reuters/Ritzau Scanpix
Listen to the article

When a cheap copy of Novo Nordisk’s weight loss pill was launched last Thursday, one wouldn’t think that just a few days later it would end up strengthening the reputation of the Danish company.

But according to journalist Hanne Sindbæk, who has chronicled Novo Nordisk in three books, the crisis has turned to the pharmaceutical giant’s advantage.

This is for subscribers' eyes only

But don’t you worry. Your Politiken Edition subscription is just one click away. We are looking forward to bringing you a handpicked selection of Politiken's stories - translated into English.

Subscribe now
Already a subscriber? Welcome back. Sign in here
Edition 2

Most read

    1

  1. The Wegovy pill exceeds every expectation. But Novo is holding back its cheers

    2. 2

  2. New international train for Danes impresses passenger: »We walk in, and the first thing we see is a bar!«

    3. 3

  3. The U.S. seeks the extradition of a Danish researcher

    4. 4

  4. The chemicals are everywhere: Not a single soil sample from Denmark is clean

    5. 5

  5. Several politicians say the electoral threshold should be raised

    6. 6

  6. Mother of murdered woman criticizes new Netflix documentary

© All material on this page is subject to the applicable copyright law.Read policy